Ask AI

Reimagining Treatment Pathways in Schizophrenia: Challenging Old Models and Creating New Solutions

Despite advances in schizophrenia treatment, many patients continue to experience persistent negative symptoms, cognitive impairment, and treatment-limiting adverse effects. Through a live symposium at Psychopharmacology Update, on-demand webcast, downloadable slides, and expert ClinicalThought commentary, healthcare professionals will gain an understanding of emerging therapeutic strategies, including novel muscarinic receptor-targeting agents, and will explore clinical evidence, mechanisms of action, and individualized treatment considerations of available pharmaceuticals. 

Share

Program Content

Events

Activities

Schizophrenia Treatment Reimagined
Reimagining Treatment Pathways in Schizophrenia: Challenging Old Models and Creating New Solutions
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by an educational grant from Bristol-Myers Squibb.

Bristol Myers Squibb